Kyndryl Faces Class Action Over Disclosure of Internal Control Deficiencies

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Kyndryl faces class action lawsuit alleging material misrepresentations about financial condition and internal controls. Stock fell 55% after disclosures of control weaknesses and executive departures.

Kyndryl Faces Class Action Over Disclosure of Internal Control Deficiencies

Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against Kyndryl Holdings, Inc., alleging the company made material misrepresentations regarding its financial condition and internal control systems. The suit covers the period from August 7, 2024, through February 9, 2026, and was initiated following a series of significant corporate disclosures that prompted substantial shareholder losses.

The legal action was triggered by several adverse developments at the information technology infrastructure company. Kyndryl announced it would be unable to file its quarterly report on a timely basis, disclosed material weaknesses in its internal controls, and announced the departure of three senior executives: its Chief Financial Officer, General Counsel, and Global Controller. These announcements precipitated a notable decline in the company's market valuation.

Following the disclosures, Kyndryl's stock price experienced a sharp decline of approximately 55 percent. The lawsuit seeks to recover damages on behalf of investors who purchased company securities during the specified period. Investors with substantial losses in Kyndryl holdings may be eligible to serve as lead plaintiffs in the litigation.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 28

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON